Ying Du

2.0k total citations
50 papers, 1.5k citations indexed

About

Ying Du is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Ying Du has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Surgery and 11 papers in Epidemiology. Recurrent topics in Ying Du's work include Adipose Tissue and Metabolism (9 papers), Pancreatic function and diabetes (9 papers) and Cancer-related molecular mechanisms research (6 papers). Ying Du is often cited by papers focused on Adipose Tissue and Metabolism (9 papers), Pancreatic function and diabetes (9 papers) and Cancer-related molecular mechanisms research (6 papers). Ying Du collaborates with scholars based in China, United States and Taiwan. Ying Du's co-authors include Feifan Guo, Qingshu Meng, Zusen Fan, Fei Xiao, Chunxia Wang, Shanghai Chen, Junjie Yu, Qian Zhang, Guanling Huang and Pingping Zhu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Ying Du

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Du China 22 746 321 307 294 234 50 1.5k
Olivier Le Bacquer France 18 1.2k 1.6× 392 1.2× 200 0.7× 187 0.6× 240 1.0× 35 1.9k
Linkang Zhou China 22 859 1.2× 527 1.6× 443 1.4× 201 0.7× 189 0.8× 33 1.6k
Yuzhi Jia United States 24 1.2k 1.7× 412 1.3× 329 1.1× 257 0.9× 158 0.7× 47 1.9k
Dmitri Samovski United States 16 990 1.3× 498 1.6× 429 1.4× 380 1.3× 248 1.1× 24 1.8k
Yu Gu China 21 778 1.0× 212 0.7× 215 0.7× 250 0.9× 98 0.4× 61 1.3k
Ahmed Bakillah United States 18 644 0.9× 198 0.6× 171 0.6× 258 0.9× 334 1.4× 47 1.4k
Nuria Martínez-López United States 20 1.0k 1.4× 401 1.2× 963 3.1× 228 0.8× 167 0.7× 26 2.1k
Agnieszka Paziewska Poland 23 1.0k 1.4× 355 1.1× 134 0.4× 357 1.2× 157 0.7× 76 1.8k
Asma Naqvi United States 21 990 1.3× 537 1.7× 294 1.0× 198 0.7× 105 0.4× 35 2.0k
Mary L. Hixon United States 21 792 1.1× 279 0.9× 215 0.7× 245 0.8× 99 0.4× 36 1.8k

Countries citing papers authored by Ying Du

Since Specialization
Citations

This map shows the geographic impact of Ying Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Du more than expected).

Fields of papers citing papers by Ying Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Du. The network helps show where Ying Du may publish in the future.

Co-authorship network of co-authors of Ying Du

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Du. A scholar is included among the top collaborators of Ying Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Du. Ying Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Li, Yingxue, Zheng Zheng, Li Wang, et al.. (2024). Association of mutation profiles with metastasis in patients with non-small cell lung cancer. Frontiers in Oncology. 14. 1451576–1451576. 2 indexed citations
5.
Du, Ying, Yijun He, Fei Shen, et al.. (2023). Declining incidence rate of tuberculosis among close contacts in five years post-exposure: a systematic review and meta-analysis. BMC Infectious Diseases. 23(1). 373–373. 2 indexed citations
6.
He, Yijun, Xuefang Cao, Yongpeng He, et al.. (2022). Serial testing of latent tuberculosis infection in patients with diabetes mellitus using interferon-gamma release assay, tuberculin skin test, and creation tuberculin skin test. Frontiers in Public Health. 10. 1025550–1025550. 5 indexed citations
7.
Xin, Henan, Xuefang Cao, Boxuan Feng, et al.. (2021). Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial. European Respiratory Journal. 60(1). 2102359–2102359. 12 indexed citations
8.
Hu, Min, Tian Gao, & Ying Du. (2021). MiR-98-3p regulates ovarian granulosa cell proliferation and apoptosis in polycystic ovary syndrome by targeting YY1. Medical Molecular Morphology. 55(1). 47–59. 9 indexed citations
9.
Yang, Shenghua, Rui‐Xia Xu, Chuan-Jue Cui, et al.. (2018). Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism. Cardiovascular Diabetology. 17(1). 48–48. 43 indexed citations
10.
Yang, Shenghua, Ying Du, Yan Zhang, et al.. (2017). Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study. BMJ Open. 7(6). e015041–e015041. 23 indexed citations
11.
Yang, Shenghua, Ying Du, Sha Li, et al.. (2016). Plasma PCSK9 level is unrelated to blood pressure and not associated independently with carotid intima–media thickness in hypertensives. Hypertension Research. 39(8). 598–605. 16 indexed citations
12.
Du, Ying, Sha Li, Chuan-Jue Cui, et al.. (2016). Leptin decreases the expression of low-density lipoprotein receptor via PCSK9 pathway: linking dyslipidemia with obesity. Journal of Translational Medicine. 14(1). 276–276. 28 indexed citations
13.
Jia, Lianqun, Nan Song, Guanlin Yang, et al.. (2016). Effects of Tanshinone IIA on the modulation of miR-33a and the SREBP-2/Pcsk9 signaling pathway in hyperlipidemic rats. Molecular Medicine Reports. 13(6). 4627–4635. 33 indexed citations
14.
Chang, Linlin, Dandan Wang, Jian Ma, et al.. (2015). Hypoxia-Targeted Drug Q6 Induces G2-M Arrest and Apoptosis via Poisoning Topoisomerase II under Hypoxia. PLoS ONE. 10(12). e0144506–e0144506. 12 indexed citations
15.
Zhu, Pingping, Yanying Wang, Ying Du, et al.. (2015). C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling. Nature Communications. 6(1). 7122–7122. 106 indexed citations
16.
Du, Ying, et al.. (2014). Central obesity and metabolic risk factors in middle-aged Chinese.. PubMed. 27(5). 343–52. 10 indexed citations
17.
Xiao, Fei, Junjie Yu, Yajie Guo, et al.. (2014). Effects of individual branched-chain amino acids deprivation on insulin sensitivity and glucose metabolism in mice. Metabolism. 63(6). 841–850. 98 indexed citations
18.
Wang, Chunxia, Tingting Xia, Ying Du, et al.. (2012). Effects of ATF4 on PGC1α expression in brown adipose tissue and metabolic responses to cold stress. Metabolism. 62(2). 282–289. 28 indexed citations
19.
Du, Ying, et al.. (2011). Effect of Tangxin Heji on Cardiac Function in Type II Diabetic Patients with Heart Failure. Journal of traditional chinese medicine. 52(19). 1658–1660. 1 indexed citations
20.
Wang, Chunxia, Xiao‐Ying Huang, Ying Du, et al.. (2010). ATF4 regulates lipid metabolism and thermogenesis. Cell Research. 20(2). 174–184. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026